Paige Chandler prosecutes U.S. and foreign patent portfolios for a wide array of clients in various life science areas. Her primary technology areas include pharmaceutical compositions, diagnostics, proteins, peptides, antibodies, antibody drug conjugates, and virotherapy. Paige drafts patent applications, conducts IP due diligence investigations, including patent evaluations, patent landscape analyses, patentability opinions, validity opinions, and freedom-to-operate opinions.
Representative clients include NGM Biopharmaceuticals, Genomatica, Hookipa Pharma, BioMarin Pharmaceutical, Inova, STCube, and Sera Prognostics.
Prior to joining Jones Day, Paige earned her Ph.D. in integrative and biomedical physiology, where her research background during her graduate studies included cancer and muscle biology. She has presented her work at several research conferences and has authored and coauthored articles in peer-reviewed journals.
- University of San Diego (currently attending law school with expected graduation in 2023); Pennsylvania State University (Ph.D. in Integrative and Biomedical Physiology 2018; M.S. in Physiology 2013); Louisiana State University (B.S. in Animal Science 2011)
- Registered to practice before the United States Patent and Trademark Office. Not licensed to practice by the State Bar of California.